Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17.
about
St. Gallen/Vienna 2015: A Brief Summary of the Consensus DiscussionAdjuvant endocrine therapy for early breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guidelineAmerican Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.Status of adjuvant endocrine therapy for breast cancer.Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole.Scientific rationale for postmenopause delay in the use of conjugated equine estrogens among postmenopausal women that causes reduction in breast cancer incidence and mortality.Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused updateDeclining incidence of contralateral breast cancer in the United States from 1975 to 2006Longer-term outcomes of letrozole versus placebo after 5 years of tamoxifen in the NCIC CTG MA.17 trial: analyses adjusting for treatment crossover.Progress in endocrine approaches to the treatment and prevention of breast cancerAdjuvant hormonal therapy in premenopausal women with breast cancer.An updated review on the efficacy of adjuvant endocrine therapies in hormone receptor-positive early breast cancer.Tamoxifen: the drug that came in from the cold.Long-term efficacy and safety of letrozole for the adjuvant treatment of early breast cancer in postmenopausal women: a reviewBreast Ductal Carcinoma In Situ: A Literature Review of Adjuvant Hormonal Therapy.Clinical practice decisions in endocrine therapy.Comparing guidelines for adjuvant endocrine therapy in postmenopausal women with breast cancer: a coming of age.Putting the cardiovascular safety of aromatase inhibitors in patients with early breast cancer into perspective: a systematic review of the literature.Extended adjuvant endocrine therapy in early breast cancer: a meta-analysis of published randomized trials.Changes in protein expression after neoadjuvant use of aromatase inhibitors in primary breast cancer: a proteomic approach to search for potential biomarkers to predict response or resistance.Long-term survival outcomes of triple-receptor negative breast cancer survivors who are disease free at 5 years and relationship with low hormone receptor positivity.Five or more years of adjuvant endocrine therapy in breast cancer: a meta-analysis of published randomised trials.Postmenopausal women with DCIS post-mastectomy: a potential role for aromatase inhibitors.
P2860
Q26801473-EB199617-4877-4FF4-8636-FB3B4A849151Q27002430-65681AE0-6EB2-41A5-99D8-E29D2EB687E9Q33631047-05328456-2872-4B68-BC08-FCE6BFFA4FBBQ33739138-DA260616-C368-4F7F-B4CB-A3EA73D3951CQ34303205-B48970B3-E5D9-4CC5-B4FF-40704081B32EQ34362281-49B8CE7F-7C34-415F-AAF0-FF321A23CA64Q34421634-56055A15-ADCC-4A96-8E60-035378DBC8B0Q34866230-11BEA022-3766-41C2-A173-7D50162A8EA5Q35808358-0FBC773E-D0A0-4FE4-86E6-7333040ECAC7Q36457511-DDB741D5-2BEB-47AB-9AB7-8B4793C26274Q36457989-55B7CAE8-4739-4FAA-AEBE-FBCD032EB6CDQ37292419-46D56829-478E-49B1-92D2-118A02D6EA96Q37345339-7624845A-CC85-4CAE-94EC-7D1790FCFAADQ37354647-0A6936EA-ACD9-4365-AC3F-27E1D530AB4DQ37527260-18DF0B42-EF4F-45CD-9325-3CECAF2B4C11Q37775019-DE34C20C-B162-400F-9BBE-B151481CB521Q37845834-DCA4E3D7-F451-41DE-AAB2-F88838015083Q37955223-7978CB87-3039-43EC-828C-AE2B3DB387F5Q38722951-788066B2-067A-4090-B907-54D286B3AD4DQ43107258-B0BD6C79-316A-4869-8D96-EFDFACD24296Q47318984-47101D94-463C-4E34-85CF-C26C5B0B4557Q47994905-6755807B-7070-4174-9885-6EA88965654FQ50938248-3A40BD61-C428-4905-8129-C2C18B5EECCD
P2860
Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Intent-to-treat analysis of th ...... breast cancer: NCIC CTG MA.17.
@en
Intent-to-treat analysis of th ...... breast cancer: NCIC CTG MA.17.
@nl
type
label
Intent-to-treat analysis of th ...... breast cancer: NCIC CTG MA.17.
@en
Intent-to-treat analysis of th ...... breast cancer: NCIC CTG MA.17.
@nl
prefLabel
Intent-to-treat analysis of th ...... breast cancer: NCIC CTG MA.17.
@en
Intent-to-treat analysis of th ...... breast cancer: NCIC CTG MA.17.
@nl
P2093
P356
P1433
P1476
Intent-to-treat analysis of th ...... breast cancer: NCIC CTG MA.17.
@en
P2093
D A Cameron
J S Abrams
K I Pritchard
L E Shepherd
M Castiglione
P304
P356
10.1093/ANNONC/MDM566
P50
P577
2008-03-10T00:00:00Z